PipelineReview.com2d
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...
PipelineReview.com2d
SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...
The Manila Times2d
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates
The latest HPRA inspection in February 2025 was highly successful-both QC licences were renewed, and viral vector manufacturing was added to the MIA (IMP) licence. This means the Shannon site can ...
PharmiWeb2d
OXB Named Among UK’s Best Employers by Financial Times in 2025
OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the Financial Times’ prestigious ‘UK Best Employers 2025’ list. This recognition ...
Labmate Online3d
Expanded manufacturing enhances life science capabilities
ProBioGen has expanded its protein and viral vector manufacturing capabilities at its Berlin headquarters, reinforcing its ...
Muscular Dystrophy News4d
AB-1003 trial for LGMD proceeds after positive recommendation
AskBio has dosed the first participant in the second group of a Phase 1/2 trial of AB-1003, an experimental gene therapy for ...
Labmate Online4d
Expanded kit range enhances AAV vector characterisation
Bio-Rad Laboratories, Inc has introduced Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 ...
PharmiWeb5d
AAVantgarde announces 2 presentations at ARVO 2025…
AAVantgarde Bio (AAVantgarde), a clinical-stage biotechnology company today announces the publication of two abstracts submitted to The Association for Research in Vision and Ophthalmology Annual ...